Belite Intangible Assets from 2010 to 2026
| BLTE Stock | USD 178.99 3.93 2.24% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 4.6 M | Current Value 2.7 M | Quarterly Volatility 1.6 M |
Check Belite Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Belite Bio's main balance sheet or income statement drivers, such as Tax Provision of 5.5 K, Net Interest Income of 4.5 M or Interest Income of 4.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 12.49. Belite financial statements analysis is a perfect complement when working with Belite Bio Valuation or Volatility modules.
Belite | Intangible Assets | Build AI portfolio with Belite Stock |
Analyzing Belite Bio's Intangible Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Intangible Assets has evolved provides context for assessing Belite Bio's current valuation and future prospects.
Latest Belite Bio's Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of Belite Bio ADR over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Belite Bio's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Belite Bio's overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
Belite Intangible Assets Regression Statistics
| Arithmetic Mean | 875,268 | |
| Geometric Mean | 94,540 | |
| Coefficient Of Variation | 184.06 | |
| Mean Deviation | 1,291,233 | |
| Median | 31,000 | |
| Standard Deviation | 1,611,046 | |
| Sample Variance | 2.6T | |
| Range | 4.6M | |
| R-Value | 0.71 | |
| Mean Square Error | 1.4T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 227,279 | |
| Total Sum of Squares | 41.5T |
Belite Intangible Assets History
About Belite Bio Financial Statements
Belite Bio stakeholders use historical fundamental indicators, such as Belite Bio's Intangible Assets, to determine how well the company is positioned to perform in the future. Although Belite Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Belite Bio's assets and liabilities are reflected in the revenues and expenses on Belite Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Belite Bio ADR. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 4.6 M | 2.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:Check out the analysis of Belite Bio Correlation against competitors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Will Biotechnology sector continue expanding? Could Belite diversify its offerings? Factors like these will boost the valuation of Belite Bio. Projected growth potential of Belite fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Belite Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Belite Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Belite Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Belite Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.